Page 20 - Indian Companies

Torrent Pharma Q4FY24 results: Net profit up 57%, revenue rises 10%

At an operational level, Torrent Pharma's earnings before interest, tax, depreciation and amortisation (Ebitda) increased by 21 per cent to Rs 883 crore

Shriram Life posts FY24 PAT at Rs 158 cr, new business premium rises 62%

Total business premium for the year ending March 31, 2024 grew by 62 per cent to Rs 1,871 crore

US-based firm Taro's shareholders approve merger with Sun Pharmaceutical

The merger agreement between Sun Pharma and Taro was approved by an affirmative vote of Taro shareholders at an extraordinary general meeting and an ordinary class meeting on May 22

Sebi proposes measures to ease ESG disclosures by listed companies

Sebi has also proposed to make the disclosures for value chain partners voluntary for the first year instead of comply or explain basis

Azad Engineering to build fully integrated advanced turbo engine for DRDO

AZAD will start delivering fully integrated advanced turbo engines by early 2026

Moved imp products out of Mohali, Dadra plants: Sun Pharma's Abhay Gandhi

Speaking to Sohini Das over a video interview from the US, Abhay Gandhi, CEO, North America of Sun Pharma outlines his plan for the company's specialty business

Mamaearth Q4 results: Records highest-ever quarterly profit at Rs 30.5 cr

The company's consolidated revenue from operations grew 21 per cent year-on-year (Y-o-Y) to Rs 471.1 crore in Q4, up from Rs 387.9 crore a year ago and Rs 488.2 crore in Q3 FY24

With expansion on mind, JSW Energy builds money purse, human capital

In April, JSW Energy completed a fund raise of Rs 5,000 crore through the qualified institutional placement (QIP) route

Fortis Healthcare Q4 results: Net profits up 46.9%, revenue rises 8.7%

The company's revenue from operations rose to Rs 1,786 crore in Q4 FY24, an 8.7 per cent Y-o-Y rise from Rs 1,643 crore reported in Q4 FY23

Google logs into Tamil Nadu for drone unit; may rope in Foxconn for Pixel

The US tech giant will manufacture drones in the state through its subsidiary Wing LLC, giving a leg up to India's plan to become a drone making hub of the world

Loans to subscriptions: Paytm feels effect of RBI curtailing Payments Bank

Paytm on Wednesday reported a 54 per cent year-on-year (Y-o-Y) decline in total loans disbursed in its financial results for 2023-24 (FY24)

SWCNTs producer NoPo Nanotechnologies raises $3 mn in pre-series A funding

NoPo specializes in the production of single-walled carbon nanotubes (SWCNTs), a material that holds promise across various applications, ranging from usage by EV battery manufacturers

Strides Pharma Q4 Results: Posts net profit of Rs 10.44 cr, revenue up 5.6%

In the same quarter of the previous fiscal, Strides reported a loss of Rs 13.79 crore. Ebitda grew 4.61 per cent to Rs 204 crore

Sebi issues framework to shield stock price impact from market rumours

Framework aimed at providing price protection to acquirers

Intellectual property rights' filing on rise amid local defence push

The target set till March 2025 for IPR is 6900 for all the organisations

Promoters reluctant to sell Haldiram Snacks despite offers by PEs

Not enthused by reported valuation of Rs 69,138 crore

Retail expansion and omnichannel plans are in place: Titan Company CFO

In an exclusive interview, Ashok Sonthalia, chief financial officer of Titan Company, discusses the company's expansion plans

JB Pharma Q4 results: Net profit soars 43% to Rs 126 cr, revenue up 13%

For the full year of FY24, JB Pharma posted an 11 per cent Y-o-Y increase in revenue and a 35 per cent increase in PAT, reaching Rs 3,484 crore and Rs 553 crore respectively

Zydus Lifesciences Q4 results: Profit rises four-fold to Rs 1,179 crore

On a sequential basis, the company exhibited a 22.83 per cent increase in revenue, the PAT also rose by 53.57 per cent

Infibeam Avenues Q4FY24 results: Net profit rises 26.2% to Rs 49.6 crore

In financial year 2024 (FY24), the company reported a net profit of Rs 158.1 crore, up 13 per cent from Rs 139.6 crore in the previous financial year (FY23)